ISRCTN54806122
Active, not recruiting
未知
Adjuvant radiotherapy in patients with high-risk primary cutaneous Squamous Cell Carcinoma AFTER surgery (SCC-AFTER): an open-label, multicentre, two-arm phase III randomised trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Adjuvant radiotherapy in patients with high-risk primary cutaneous Squamous Cell Carcinoma AFTER surgery
- Sponsor
- Cardiff University
- Enrollment
- 840
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. High\-risk primary cSCC (T2b/T3 by BWH staging criteria) excised with adequate peripheral and deep surgical margins (according to BAD guidelines) with histologically clear margins (\=1mm by Royal College of Pathology criteria
- •2\. Time since excision surgery \< 3 months (\<2 months is preferred)
- •3\. ECOG performance status of 3 or less at enrolment
- •4\. Aged 18 years or older at time of consent
- •5\. Fit for ART and able to attend radiotherapy outpatient appointments
- •6\. Life expectancy \>6 months
- •7\. Informed Consent obtained\* which must be prior to any mandatory study\-specific procedures, sampling, and analyses
Exclusion Criteria
- •1\. Any current clinicopathological evidence of loco\-regional recurrence of the index tumour
- •2\. Previous (within 3 years) or current non\-index primary cSCC in skin drained by the same lymph node basin
- •3\. cSCC on anatomical sites which interfere with suitability for ART (such as vermilion lip, eyelids, breast, anogenital area)
- •4\. Patients with evidence of regional or distant disease at time of primary cSCC diagnosis
- •5\. Previous radiotherapy in the same area
- •6\. Patients with reproductive potential who are not willing to use contraception for the duration from trial consent until the last dose of radiotherapy if they are randomised to the ART arm
- •7\. Unable to lie still unattended for the duration of ART (estimated to be around 5 minutes)
- •8\. Participation in another interventional clinical study that may affect the recurrence of cSCC (primary endpoint)
- •9\. History of another malignancy where metastasis could cause diagnostic uncertainty or patients receiving active systemic anti\-cancer treatment (excluding hormonal treatment for prostate or breast cancer) or radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC-1): a multicenter phase II study(pre)malignant tumors in periampular region10017990NL-OMON54875Academisch Medisch Centrum33
Recruiting
Not Applicable
Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC): a multicenter phase II studyMalignant and premalignant periampullary tumors, excluding pancreatic adenocarcinoma.NL-OMON21296A33
Completed
Not Applicable
Adjuvant radiation of patients with involvement of mediastinal lymph nodes (pN2) and complete resection of Non Small Cell Lung Cancer: a retrospective analysis of patients of the department of Radiation Oncology FreiburgC34Malignant neoplasm of bronchus and lungDRKS00008887niversitätsklinikum Freiburg61
Not yet recruiting
Phase 2
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042)NL-OMON32223EORTC30
Completed
Not Applicable
Post-Operative Radiotherapy for Selected High Risk Rectal AdenocarcinomaColorectal cancerCancerColorectalISRCTN91411631orthern and Yorkshire Clinical Trials and Research Unit (UK)